Latest Manufacturing News

Nanollose Limited has completed a successful pilot manufacturing run blending its Nullarbor-20 fibre with wool, raised $1.05 million through an entitlement issue, and appointed Andrew Moullin as CEO to drive its commercialisation strategy.

DTI Group Limited has successfully completed a $2.69 million entitlement offer, marked a key milestone with the first installation of the Flexity tram, and secured over $2 million in new contracts during the June 2025 quarter.

Foresta Group Holdings secures a critical extension from New Zealand's Overseas Investment Office and partners with EECA to explore geothermal energy use, pushing forward its flagship Kawerau biomass project.

Cardiex reported strong growth in its Pulse arterial health monitor sales during Q4 FY25, surpassing A$0.7 million for the year and advancing its transition to subscription-based digital health services.

Wellnex Life Limited reported a robust Q4 FY25 with a 22% sales increase and positive operational cash flow, underpinning its strategic growth initiatives backed by new debt funding.

Quantum Graphite Limited has made significant strides in developing its Eyre Peninsula Graphite Hub, progressing detailed planning with government stakeholders and attracting new financiers for its Uley 2 project. Exploration and purification testwork updates promise to refine its resource and product quality outlook.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.

RooLife Group (ASX, RLG) reported $1 million revenue in Q4 FY2025, driven by its UK TikTok marketplace launch and a major solar product order from India, while divesting its digital marketing arm and cutting staff costs.

Papyrus Australia has made significant strides in Q2 2025, launching its Rapid Prototyping and R&D Facility and successfully trialling new banana fibre-based products, while deepening academic partnerships.

Atomos Limited faced a challenging Q4 FY25 with US tariff disruptions but rebounded strongly in June, launching new products and appointing Peter Barber as CEO to drive future growth.

Argent BioPharma has achieved a significant milestone by commencing formal supply of its EU-GMP cannabinoid API for epilepsy treatment at a leading Slovenian hospital and gaining prescription approval for CannEpil™ in Germany, marking key steps in its European expansion.

Viridis Mining and Minerals has been selected for up to US$903 million in Brazilian government funding to advance its Colossus Rare Earth Project, while delivering Brazil’s first locally sourced rare earth oxides and posting robust Pre-Feasibility Study results.